# Intranasal Sufentanil Versus Intravenous Morphine for the Management of Acute Pain

> **NCT03224039** · PHASE4 · UNKNOWN · sponsor: **The Brooklyn Hospital Center** · enrollment: 40 (estimated)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Sufentanil
- **DRUG:** Normal saline
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT03224039
- **Lead sponsor:** The Brooklyn Hospital Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2019-01-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03224039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03224039, "Intranasal Sufentanil Versus Intravenous Morphine for the Management of Acute Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03224039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*